Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07192055 · ClinicalTrials.gov registry record · NA
Self-sampling to Optimize Anal Lesion Outcomes
A NA study of Anal Cancer, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- NA
- Development phase
- 572
- Enrollment target
- 3
- Study locations
NCT07192055: Recruiting NA study of Anal Cancer, sponsored by Medical College of Wisconsin.
NCT07192055 is a NA study of Anal Cancer that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 572 participants, roughly in line with the 550-participant average among 19 other Anal Cancer trials with a reported enrollment target. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07192055, a NA study of Anal Cancer, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- NA
- Development phase
- 572 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research study is to find ways to increase anal cancer screening among people at increased risk for anal cancer. This study will try to find out if persons will do an intervention (self-sampling of the anal canal) and if it affects cytology and high-resolution anoscopy (HRA) appointment attendance. Secondarily, the study will assess if a person who gets their choice of either self-sampling or healthcare provider sampling affects clinic attendance.
Primary Outcome
Determine the number of individuals who attend the cytology appointment after exposure to the self-sampling intervention.
Conditions Studied
Interventions
- BEHAVIORAL Self-sampling
- OTHER Nylon-flocked Swab
Study Locations (3)
Illinois
- University of Chicago - Chicago
Texas
- The University of Texas M.D. Anderson Cancer Center - Houston
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 572 participants |
| Start Date | 2025-11-18 |
| Est. Completion | 2029-03-31 |
| Phase | NA |
What NCT07192055 shows while recruiting
NCT07192055 is an interventional study that assigns participants to a tested intervention. The registered 572 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 550-participant average among 19 other Anal Cancer trials with a reported enrollment target.
The record links to 1 condition, with Anal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Self-sampling is the first listed.
NCT07192055 reports a single indexed study location in Illinois, Texas, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07192055 about?
NCT07192055 is a clinical study titled "Self-sampling to Optimize Anal Lesion Outcomes". The purpose of this research study is to find ways to increase anal cancer screening among people at increased risk for anal cancer. This study will try to find out if persons will do an intervention (self-sampling of the anal canal) and if it affects cytology and high-resolution anoscopy (HRA) appo...
What is the current status of trial NCT07192055?
This trial is currently recruiting. It is a NA study. The enrollment target is 572 participants. The study started on 2025-11-18. Estimated completion is 2029-03-31.
What conditions does trial NCT07192055 study?
This clinical trial studies the following conditions: Anal Cancer.
What interventions are being tested in trial NCT07192055?
The interventions under investigation include: Self-sampling (BEHAVIORAL), Nylon-flocked Swab (OTHER).
Who is sponsoring clinical trial NCT07192055?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07192055 being conducted?
This trial has 3 study locations across Illinois, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07192055's enrollment target sits among peer trials
572 3rd of 19 higher than 17 of 19 other Anal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
-
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
COMPLETED · NA
-
Assessing THE GAY Male Experience With Anal Cancer Prevention Strategies
RECRUITING
-
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RECRUITING · Phase 2
-
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
RECRUITING
-
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05131022 · 572 participants · Phase 1
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- NCT06346392 · 572 participants · Phase 3
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
- NCT06615050 · 572 participants · Phase 3
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- NCT05977751 · 573 participants · NA
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI